| Dermatology and Skin Diseases | Lifetime | 25 | US 15 | 99.78 |
| Psoriasis: Treatment and Pathogenesis | Lifetime | 17 | US 8 | 99.76 |
| Pharmaceutical studies and practices | Lifetime | 28 | US 20 | 99.46 |
| Autoimmune Bullous Skin Diseases | Lifetime | 34 | US 16 | 99.46 |
| Asthma and respiratory diseases | Lifetime | 175 | US 67 | 99.51 |
| Allergic Rhinitis and Sensitization | Lifetime | 227 | US 66 | 99.01 |
| Immunodeficiency and Autoimmune Disorders | Lifetime | 291 | US 135 | 98.57 |
| Immunotherapy and Immune Responses | Lifetime | 764 | US 396 | 98.82 |
| Biosimilars and Bioanalytical Methods | Lifetime | 117 | US 43 | 97.55 |
| Cytomegalovirus and herpesvirus research | Lifetime | 788 | US 421 | 97.06 |
| Viral-associated cancers and disorders | Lifetime | 619 | US 290 | 96.93 |
| Autoimmune and Inflammatory Disorders Research | Lifetime | 493 | US 143 | 97.02 |
| Food Allergy and Anaphylaxis Research | Lifetime | 479 | US 136 | 96.88 |
| Urticaria and Related Conditions | Lifetime | 551 | US 172 | 95.74 |
| Mast cells and histamine | Lifetime | 817 | US 277 | 93.53 |
| Cutaneous lymphoproliferative disorders research | Lifetime | 981 | US 384 | 92.12 |
| Dermatology and Skin Diseases | 2021-2025 | 6 | US 5 | 99.84 |
| Psoriasis: Treatment and Pathogenesis | 2021-2025 | 3 | US 2 | 99.82 |
| Pharmaceutical studies and practices | 2021-2025 | 3 | US 2 | 99.50 |
| Asthma and respiratory diseases | 2021-2025 | 12 | US 3 | 99.76 |
| Allergic Rhinitis and Sensitization | 2021-2025 | 29 | US 9 | 99.43 |
| Autoimmune Bullous Skin Diseases | 2021-2025 | 17 | US 7 | 99.12 |
| Cytokine Signaling Pathways and Interactions | 2021-2025 | 14 | US 6 | 97.21 |
| Food Allergy and Anaphylaxis Research | 2021-2025 | 45 | US 19 | 98.69 |
| Urticaria and Related Conditions | 2021-2025 | 49 | US 12 | 97.63 |
| Health Systems, Economic Evaluations, Quality of Life | 2021-2025 | 298 | US 97 | 97.02 |
| Mast cells and histamine | 2021-2025 | 89 | US 24 | 93.33 |
| Immunodeficiency and Autoimmune Disorders | 2021-2025 | 361 | US 106 | 91.54 |
| Spondyloarthritis Studies and Treatments | 2021-2025 | 260 | US 40 | 92.69 |
| IL-33, ST2, and ILC Pathways | 2021-2025 | 254 | US 91 | 88.16 |
| Biosimilars and Bioanalytical Methods | 2021-2025 | 272 | US 106 | 88.05 |
| Autoimmune and Inflammatory Disorders Research | 2021-2025 | 834 | US 143 | 84.63 |
| Retinoids in leukemia and cellular processes | 2021-2025 | 319 | US 108 | 71.84 |
| Nonmelanoma Skin Cancer Studies | 2021-2025 | 948 | US 286 | 72.82 |
| Complementary and Alternative Medicine Studies | 2021-2025 | 616 | US 118 | 70.88 |
| Transgenic Plants and Applications | 2021-2025 | 379 | US 71 | 69.97 |
| Adrenal Hormones and Disorders | 2021-2025 | 784 | US 109 | 67.74 |
| Herbal Medicine Research Studies | 2021-2025 | 324 | US 15 | 48.37 |
